Key result
Universal screening for high-sensitivity C-reactive protein in patients with atherosclerotic disease represents a major therapeutic opportunity.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The authors discuss the therapeutic opportunity of universal screening for hsCRP in patients with atherosclerotic disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liuzzo et al. (2024) studied this question. Universal screening for high-sensitivity C-reactive protein in patients with atherosclerotic disease represents a major therapeutic opportunity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: